Full-Time
Applications Engineer
Technical Sales & Support
Halma
1,001-5,000 employees
Global safety, health, environmental technology company
Compensation Overview
$50k - $60k/yr
Tucson, AZ, USA
In Person
On-site in Tucson, Arizona.
Bachelor's
 Sales & Solution Engineering (1) |
|---|
Get referred to Halma
See people who can refer or advise you
- A Bachelor's degree in Engineering, Physics, or a related STEM field is preferred.
- Strong written and verbal communication skills are required.
- Experience or interest in fluid control, instrumentation, or automation is required.
- Familiarity with aerospace, bioprocessing, chemistry, environmental science, semiconductor technology, or optical sciences is a plus.
- Experience in technical sales, customer support, or application engineering is a bonus but is not required.
- Complete the comprehensive product and application training program.
- Develop proficiency in core product knowledge and internal customer-management tools.
- Respond to customer inquiries with supervision, providing accurate technical and sales support.
- Establish working relationships with Sales, Engineering, and Production teams.
- Support the full product line and handle customer communication independently.
- Troubleshoot standard technical issues and provide accurate, timely support.
- Solve advanced application challenges and support complex customer accounts.
- Identify inefficiencies and help coordinate team-wide process improvements.
- Set a strong example for peers and contribute to shaping team standards and culture.
- Serve as the first point of contact for inbound inquiries via phone, email, and live chat.
- Qualify customer needs and recommend tailored solutions aligned with technical and business goals.
- Build accurate, application-specific quotes and follow up to drive conversions.
- Support original equipment manufacturers and distribution partners with quoting and technical guidance.
- Troubleshoot flow instability, pressure regulation challenges, mechanical operations, and chemical incompatibilities.
- Remotely diagnose and resolve communication errors by investigating hardware issues, including wiring, power, and signal integrity, and software-based networking problems.
- Work with engineering, production, and marketing teams to support customer satisfaction and product alignment.
- Contribute to product documentation and marketing content.
- Enter and manage sales and service orders for smooth processing and timely fulfillment.
- Maintain customer relationship management records for communication, order tracking, and customer history.
- Collaborate with internal teams to capture and execute customer requirements.
- Contribute to revenue growth by converting inquiries into sales opportunities.
- Confidently support the full product line and manage customer workflows.
- A Bachelor's degree in Engineering, Physics, or a related STEM field.
- Familiarity with aerospace, bioprocessing, chemistry, environmental science, semiconductor technology, or optical sciences.
- Experience in technical sales, customer support, or application engineering.
Halma is a global holding company focused on safety, health, and environmental technologies. It builds a diversified portfolio by acquiring firms with strong intellectual property and growth potential, totaling over 200 acquisitions since 1972, with active businesses in sensors, safety, and medical technology. How it works: Halma's subsidiaries develop and sell products and systems that detect hazards, monitor health, and protect people and environments. These include sensor-based devices and safety technologies, often integrated into industrial, medical, and consumer applications. The company relies on the expertise and IP of its acquired businesses rather than one single product line, operating through a network of specialized units rather than a centralized product.”
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Milton Keynes, United Kingdom
Founded
1894
Get referred to Halma
See people who can refer or advise you
Simplify's Take
What believers are saying
- FY2026 revenue rose 15% to £2.58 billion, with adjusted EBIT up 22% to £594.5 million.
- Halma completed Dreampath in July 2026, expanding healthcare into a growing diagnostics workflow market.
- Marc Ronchetti targets low-double-digit organic growth in FY2027, backed by acquisition firepower.
What critics are saying
- One photonics customer drove 20% of group revenue in FY2026, concentrating earnings risk.
- FY2027 photonics growth drops from 52% to 30%, compressing the biggest growth engine.
- Constance Baroudel leaves in August 2026; leadership churn can slow execution across sectors.
What makes Halma unique
- Halma’s 200-plus bolt-ons compound niche IP into sticky safety, healthcare, and environmental franchises.
- Dreampath adds closed-loop pathology automation with hardware, software, and recurring consumables.
- Avo Photonics gives Halma proprietary photonics exposure serving data-center and precision-technology customers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Remote Work Options
Health Insurance
Dental Insurance
Vision Insurance
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Stock Options
Company Equity
Family Planning Benefits
Fertility Treatment Support
Parental Leave
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
Phone/Internet Stipend
Home Office Stipend
401(k) Retirement Plan
401(k) Company Match
Remote Work Options
Company News
FTSE 100 movers: Shell gushes higher after update; miners in the red. London's FTSE 100 was up 0.4% at 10,694.03 in afternoon trade on Tuesday. Drinks maker Diageo and consumer goods giant Unilever were among the top gainers. Shell also gushed higher as the oil giant said trading & optimisation earnings in its integrated gas division are expected to be "significantly" higher in the second quarter as it lifted its production guidance for the segment. The company expects Q2 production of 610,000 to 650,000 barrels of oil equivalent per day in its integrated gas arm, down from 909,000 boed in the first quarter due to the impact of the Middle East conflict on Qatari volumes. However, this was above its previous forecast for production of 580,000 to 640,000 boed in Q2. Shell also said it expects an improvement in its working capital position due to the impact of "unprecedented volatility" in commodity prices. It now expects a cash inflow of $1bn to $6bn in the second quarter, following a $11.2bn outflow in the first quarter. Heavily-weighted miners Anglo American and Antofagasta were under the cosh, along with precious metals miner Fresnillo, as gold prices fell. Halma retreated after announcing the acquisition of France-based Dreampath Diagnostics for an initial €154m (£132m), on a cash- and debt-free basis. FTSE 100 - Risers FTSE 100 - Fallers
Halma (LSE:HLMA) has entered into an agreement to acquire Strasbourg-based Dreampath Diagnostics, a specialist in automated solutions for tracking, storing and managing patient tissue samples used in anatomical pathology laboratories. Dreampath has developed a closed-platform system that combines hardware, software and recurring consumables to streamline complex laboratory workflows.
Halma has agreed to acquire Dreampath Diagnostics, a French provider of automated sample-tracking systems for pathology labs, for an initial €154 million. The deal includes a potential earn-out of up to €121 million based on performance through March 2028. Strasbourg-based Dreampath specialises in helping labs store, track and manage patient tissue samples throughout diagnostics. Its closed-loop system combines hardware, software and consumables, generating recurring revenue. The company is expected to post €33 million in revenue for the 12 months ending March 2027. The acquisition expands Halma's healthcare portfolio, adding capabilities in tissue sample management. Dreampath will operate as a standalone business, keeping its current management team. Group chief executive Marc Ronchetti said the deal positions Halma in a growing diagnostics market driven by aging populations and rising chronic disease rates.
Halma plc, the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, today announces that it has acquired itemedical and Naslund Medical for its Healthcare sector companies SSG and IZI Medical. These bolt-on acquisitions strengthen Halma’s
Halma shares plunge despite record revenue and profit. Shares in Halma (LON: HLMA) plummeted more than 11% on Thursday - shedding over 510p to trade around 4,128p - as investors took fright at customer concentration risks in its fast-growing photonics division, even as the FTSE 100 safety and technology group delivered a string of record financial results. For the 12 months to 31 March 2026, Halma grew revenue 15% to £2.58 billion and adjusted earnings before interest and tax (EBIT) 22% to £594.5 million, both surpassing City forecasts and crossing the £2.5 billion and £500 million milestones for the first time. It was also the company's 23rd consecutive year of adjusted profit growth. Organic revenue rose 16%, with the photonics business - which serves the booming data centre industry - contributing around eight percentage points of that growth. However, analysts and investors flagged a growing concern: revenue from a single photonics customer climbed from 15% to 20% of group sales during the year, raising concentration risk warnings. Halma invested a record £600 million during the year, including £447 million across five acquisitions, with two further deals worth around £75 million completed after the year-end. Adjusted cash conversion remained healthy at 93%, ahead of its 90% target, while net debt stood at a comfortable 1.16 times adjusted EBITDA. The board raised its total dividend 7% to 24.74p per share - a 47th consecutive year of growth of 5% or more - though the payout came in slightly below the 25.9p the market had anticipated. Looking ahead, Halma guided for low double-digit organic revenue growth in FY2027, but with shares trading at roughly 36 times forward earnings - well above a sector average of 22 times - analysts at Panmure Liberum noted the premium valuation leaves little room for any disappointment. Searching for the perfect broker? Discover its top-recommended brokers for trading or investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today! * IG Top-tier regulation - Read its Review * eToro Wide range of instruments available to trade - Read its Review YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY Team Member The AskTraders Analyst Team features experts in technical and fundamental analysis, as well as traders specializing in stocks, forex, and cryptocurrency.